Correlation Between Regeneron Pharmaceuticals and Abcellera Biologics
Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regeneron Pharmaceuticals and Abcellera Biologics, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and Abcellera Biologics.
Diversification Opportunities for Regeneron Pharmaceuticals and Abcellera Biologics
-0.66 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Regeneron and Abcellera is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and Abcellera Biologics go up and down completely randomly.
Pair Corralation between Regeneron Pharmaceuticals and Abcellera Biologics
Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to generate 0.42 times more return on investment than Abcellera Biologics. However, Regeneron Pharmaceuticals is 2.37 times less risky than Abcellera Biologics. It trades about 0.0 of its potential returns per unit of risk. Abcellera Biologics is currently generating about -0.05 per unit of risk. If you would invest 72,047 in Regeneron Pharmaceuticals on September 23, 2024 and sell it today you would lose (1,862) from holding Regeneron Pharmaceuticals or give up 2.58% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Regeneron Pharmaceuticals vs. Abcellera Biologics
Performance |
Timeline |
Regeneron Pharmaceuticals |
Abcellera Biologics |
Regeneron Pharmaceuticals and Abcellera Biologics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Regeneron Pharmaceuticals and Abcellera Biologics
The main advantage of trading using opposite Regeneron Pharmaceuticals and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.Regeneron Pharmaceuticals vs. Fate Therapeutics | Regeneron Pharmaceuticals vs. Sana Biotechnology | Regeneron Pharmaceuticals vs. Caribou Biosciences | Regeneron Pharmaceuticals vs. Arcus Biosciences |
Abcellera Biologics vs. Fate Therapeutics | Abcellera Biologics vs. Sana Biotechnology | Abcellera Biologics vs. Caribou Biosciences | Abcellera Biologics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |